Definitive Healthcare (DH)
(Delayed Data from NSDQ)
$3.74 USD
-0.16 (-4.10%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Definitive Healthcare Corp. has a PEG ratio of 1.28 compared to the Internet - Software industry's PEG ratio of 2.23.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DH 3.74 -0.16(-4.10%)
Will DH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DH
Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates
New Strong Sell Stocks for March 4th
DH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates
Magnite (MGNI) Matches Q4 Earnings Estimates
Intuit Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
Other News for DH
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | DH ...
Definitive Healthcare Q1 Review: Revenue Slumps, Structural Issues Surface, And A SELL Rating Sticks
Definitive Healthcare (DH) Grants Inducement Award to New Executive | DH Stock News
Definitive Healthcare reports inducement grants under Nasdaq listing rule
Definitive Healthcare reports inducement grants under Nasdaq listing rule